Articles
Prostate Cancer Risk Reduced in Men with Very Low Free Testosterone
By Jody A. Charnow – Renal and Urology News 08/03/2018“…Men with low levels of circulating free testosterone may be at lower risk
Balloon therapy surgery developed by Overland Park urologist helping men with incontinence
By Sean McDowell – Fox4kc.com 07/27/2018 “…That’s a certainty for men who’ve had prostate cancer surgery, many of whom suffer from the
Researchers uncover cause for progression of prostate cancer to incurable stage
By News-Medical.net 07/20/2018 “…Prostate cancer is the second most common cancer and the fifth leading cause of cancer-related death in
U.S. launches study to understand black men and prostate cancer
By Maggie Fox – NBCNews.com 07/17/2018 “…Black men are twice as likely to die of prostate cancer as white men. Government
UC San Diego Health now offers new treatment option for men with enlarged prostate
By news-medical.net 07/10/2018 “…Physicians at UC San Diego Health are now offering prostate artery embolization (PAE) as a new treatment option
Prostate cancer: Scientists find 63 ‘new genetic markers’
By Monica Beyer – Medical News Today 06/18/2018 “…A 6-year research project identifies 63 gene changes that could help to indicate
Prostate cancer breakthrough as new drug keeps men with previously ‘untreatable’ cases alive
By Henry Bodkin – The Telegraph 06/02/2018 “…Men with previously “untreatable” prostate cancer are being kept alive by a new drug in what experts
Prostate cancer immune system drug results could be ‘spectacular’
By James Gallagher – BBC News 06/02/2018 “…Drugs that boost the immune system have saved the lives of some men
Prostate cancer: Help to improve ‘disheartening’ awareness levels
By BBC 04/22/2018 “…Cancer of the prostate – which is a small gland in the pelvis – affects one in
Prostate cancer research has had a £75m welcome boost. Now let’s treat another killer of men
By Phil Whitaker – Newstatesman.com 04/22/2018 “…The opening months of 2018 have seen a flurry of activity in men’s health.